| Growth factors influencing bone development JM Wozney, V Rosen, M Byrne, AJ Celeste, I Moutsatsos, EA Wang Journal of Cell Science 1990 (Supplement_13), 149-156, 1990 | 269 | 1990 |
| Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia GL Uy, I Aldoss, MC Foster, PH Sayre, MJ Wieduwilt, AS Advani, ... Blood, The Journal of the American Society of Hematology 137 (6), 751-762, 2021 | 242 | 2021 |
| Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT P Tsirigotis, M Byrne, C Schmid, F Baron, F Ciceri, J Esteve, NC Gorin, ... Bone marrow transplantation 51 (11), 1431-1438, 2016 | 222 | 2016 |
| Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American … T Jain, M Bar, AJ Kansagra, EA Chong, SK Hashmi, SS Neelapu, M Byrne, ... Biology of Blood and Marrow Transplantation 25 (12), 2305-2321, 2019 | 162 | 2019 |
| Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy B Estfan, M Byrne, R Kim American journal of clinical oncology 36 (4), 319-324, 2013 | 137 | 2013 |
| Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission A Rashidi, M Hamadani, MJ Zhang, HL Wang, H Abdel-Azim, M Aljurf, ... Blood advances 3 (12), 1826-1836, 2019 | 106 | 2019 |
| Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and … D Buchbinder, DL Kelly, RF Duarte, JJ Auletta, N Bhatt, M Byrne, ... Bone marrow transplantation 53 (5), 535-555, 2018 | 95 | 2018 |
| The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia M Yeshurun, D Weisdorf, JM Rowe, MS Tallman, MJ Zhang, HL Wang, ... Blood advances 3 (4), 670-680, 2019 | 92 | 2019 |
| Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and … Y Inamoto, N Valdés-Sanz, Y Ogawa, M Alves, L Berchicci, J Galvin, ... Bone marrow transplantation 54 (5), 662-673, 2019 | 89 | 2019 |
| Eprenetapopt plus azacitidine after allogeneic hematopoietic stem-cell transplantation for TP53-mutant acute myeloid leukemia and myelodysplastic syndromes A Mishra, R Tamari, AE DeZern, MT Byrne, M Gooptu, YB Chen, HJ Deeg, ... Journal of Clinical Oncology 40 (34), 3985-3993, 2022 | 76 | 2022 |
| Understanding and managing large B cell lymphoma relapses after chimeric antigen receptor T cell therapy M Byrne, OO Oluwole, B Savani, NS Majhail, BT Hill, FL Locke Biology of Blood and Marrow Transplantation 25 (11), e344-e351, 2019 | 67 | 2019 |
| Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma RW Merryman, L Castagna, L Giordano, VT Ho, P Corradini, A Guidetti, ... Leukemia 35 (9), 2672-2683, 2021 | 58 | 2021 |
| Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the Late Effects and Quality of Life Working Committee of the Center for … DL Kelly, D Buchbinder, RF Duarte, JJ Auletta, N Bhatt, M Byrne, ... Biology of Blood and Marrow Transplantation 24 (2), 228-241, 2018 | 58 | 2018 |
| Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation R Kim, G El-Gazzaz, A Tan, P Elson, M Byrne, YD Chang, F Aucejo Oncology 79 (1-2), 62-66, 2010 | 57 | 2010 |
| Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies MA Fischer, SY Friedlander, MP Arrate, H Chang, AE Gorska, LD Fuller, ... Blood advances 4 (3), 586-598, 2020 | 54 | 2020 |
| Machine learning reveals chronic graft-versus-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies JS Gandelman, MT Byrne, AM Mistry, HG Polikowsky, KE Diggins, ... Haematologica 104 (1), 189, 2019 | 53 | 2019 |
| The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia M Byrne, N Danielson, S Sengsayadeth, A Rasche, K Culos, K Gatwood, ... American Journal of Hematology 95 (9), 1006-1014, 2020 | 51 | 2020 |
| Mechanisms of oncogenic chromosomal translocations M Byrne, J Wray, B Reinert, Y Wu, J Nickoloff, SH Lee, R Hromas, ... Annals of the New York Academy of Sciences 1310 (1), 89-97, 2014 | 51 | 2014 |
| Poor peripheral blood stem cell mobilization affects long‐term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation JS Moreb, M Byrne, I Shugarman, F Zou, S Xiong, WS May, M Norkin, ... Journal of clinical apheresis 33 (1), 29-37, 2018 | 43 | 2018 |
| Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide A Im, A Rashidi, T Wang, M Hemmer, ML MacMillan, J Pidala, M Jagasia, ... Biology of blood and marrow transplantation 26 (8), 1459-1468, 2020 | 41 | 2020 |
